CRISPR Therapeutics Jumps on Takeover Buzz CRISPR Therapeutics stock surges 6% amid fresh speculation that Vertex Pharmaceuticals may pursue an acquisition. Credit: Gregor Fischer/picture alliance/Getty Images Subscribe now Already have an account? Sign in.
